Heidelberg, Germany

Arthur Lanziner

This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Carl Freudenberg Kg. Active years: 2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Arthur Lanziner: Innovator in Curable Fluoroelastomers

Introduction

Arthur Lanziner is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of materials science, particularly in the development of curable fluoroelastomers. His innovative work has led to the creation of a unique composition that addresses specific challenges in the industry.

Latest Patents

Arthur Lanziner holds a patent for "Curable fluoroelastomers having low swelling tendency." This invention relates to a curable fluoroelastomer composition that includes a curable fluoroelastomer, a curing system, and a nitrogen-containing polymer. The nitrogen-containing polymer is present in particulate form or fiber form, which enhances the properties of the fluoroelastomer, making it suitable for various applications.

Career Highlights

Throughout his career, Lanziner has worked with prominent companies such as Carl Freudenberg KG and ElringKlinger AG. His experience in these organizations has allowed him to refine his expertise in elastomer technology and contribute to innovative solutions in the field.

Collaborations

Some of his notable coworkers include Marina Nussko and Peter Feigl. Their collaboration has likely fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Arthur Lanziner's contributions to the development of curable fluoroelastomers demonstrate his commitment to innovation in materials science. His patent reflects a significant advancement that addresses industry needs, showcasing his role as a key inventor in this domain.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…